However, delineating mechanisms of monocyte function is hampered by inconsistent results among studies. Approach and Results-We use cytometry by time-of-flight mass cytometry to profile human monocytes using a panel of 36 cell surface markers. Using the dimensionality reduction approach visual interactive stochastic neighbor embedding (viSNE), we define monocytes by incorporating all cell surface markers simultaneously. Using viSNE, we find that although classical monocytes are defined with high purity using CD14 and CD16, intermediate and nonclassical monocytes defined using CD14 and CD16 alone are frequently contaminated, with average intermediate and nonclassical monocyte purity of ≈86.0% and 87.2%, respectively. To improve the monocyte purity, we devised a new gating scheme that takes advantage of the shared coexpression of cell surface markers on each subset. In addition to CD14 and CD16, CCR2, CD36, HLA-DR, and CD11c are the most informative markers that discriminate among the 3 monocyte populations. Using these additional markers as filters, our revised gating scheme increases the purity of both intermediate and nonclassical monocyte subsets to 98.8% and 99.1%, respectively. We demonstrate the use of this new gating scheme using conventional flow cytometry of peripheral blood mononuclear cells from subjects with cardiovascular disease. Conclusions-Using cytometry by time-of-flight mass cytometry, we have identified a small panel of surface markers that can significantly improve monocyte subset identification and purity in flow cytometry. Such a revised gating scheme will be useful for clinical studies of monocyte function in human cardiovascular disease. Visual Overview-An online visual overview is available for this article. CD36, CD64, CD62L, HLA-DR, CX3CR1, SLAN, and  CD11c . 2, 12, 13 One approach to minimize the inconsistencies that arise from the arbitrary gate placement using CD14 and CD16 alone is to combine multiple informative cell surface markers.
M
onocytes are a major component of human peripheral blood, accounting for ≈10% of all circulating leukocytes. Human monocytes are traditionally divided into 3 phenotypically and functionally distinct populations based on differences in expression of CD14 and CD16 encoding for the lipopolysaccharide receptor and the low-affinity FC γ receptor, respectively. Classical (CD14 hi CD16 neg ) monocytes account for 80% to 90% of human blood monocytes, intermediate (CD14 hi CD16 hi ) monocytes comprise ≈2% to 5%, and the nonclassical (CD14 low CD16 hi ) monocytes account for the remaining 2% to 10%. 1, 2 Multiple diseases, including bacterial and viral infections, autoimmunity, and chronic inflammation, are associated with changes in monocyte subsets. Intermediate monocytes are more abundant in bacterial sepsis, 3 dengue fever, 4 Crohn's disease, 5 cardiovascular disease (CAD), 6 and rheumatoid arthritis, 7 whereas the nonclassical monocytes are more prevalent in periodontitis 8 and reduced in stroke. 9 There has been considerable interest surrounding the precise contributions of the various monocyte subsets to human disease. 2 Yet, there is still uncertainty concerning the relative contribution of each subset in disease, in part due to conflicting reports concerning the functions of each subset. Monocytes are typically gated in flow cytometry using either a quadrant-based or trapezoid-based gating scheme using CD14 and CD16 to distinguish among the 3 monocyte subsets. 10, 11 Regardless of the approach, the placement of gates discriminating among the monocyte subpopulations is an inherently subjective exercise. Genome-wide analyses and cytometric profiling studies have identified a repertoire of cell surface markers that are differentially expressed on the 3 monocyte subsets, including CCR2, CD36, CD64, CD62L, HLA-DR, CX3CR1, SLAN, and CD11c. 2, 12, 13 One approach to minimize the inconsistencies that arise from the arbitrary gate placement using CD14 and CD16 alone is to combine multiple informative cell surface markers. 14, 15 However, technical limitations in flow cytometry have limited the number of cell surface markers that can be accurately analyzed simultaneously. Furthermore, there is a lack of analytic approaches that can effectively demonstrate the improvement provided by a given gating scheme.
The advent of mass cytometry (cytometry by time-of-flight [CyTOF] ) and the development of flow cytometers capable of detecting in excess of 25 colors have provided the technical means to overcome these challenges. CyTOF uses heavy metalconjugated antibodies in tandem with time-of-flight mass spectrometry to measure protein abundances at a single-cell resolution. 16 The discrete nature of heavy metal mass to charge ratios overcomes the limits imposed by fluorescence spectral overlap in flow cytometry, 16, 17 which dramatically increases the number of markers that can be measured simultaneously. This large increase in dimensionality of data has precipitated an analytic burden, rendering the manual, iterative, approach to gating and cell subset classification ineffective. 18 Computational methods that rely on dimensionality reduction are a powerful solution to these issues. One such approach, termed visual interactive stochastic neighbor embedding (viSNE), provides a single-cell visual representation of cell-cell relationships using a t-distributed stochastic neighbor embedding algorithm. 18, 19 The resulting plot generated by viSNE positions cells on a 2-dimensional scatter plot using information borrowed from every marker used in an experiment.
We reasoned that using CyTOF and viSNE would provide a powerful approach to phenotype the human monocyte subsets. Here, we use a panel of 36 cell surface markers expressed on myeloid cells to profile human blood monocytes, confirming previous reported surface marker expression profiles. Importantly, using viSNE, we find that monocytes gated using CD14 and CD16 alone lead to frequent misclassification and cross-contamination between populations. Using a factorial analysis approach, we identify the cell surface markers that best discriminate between the monocyte subsets. Furthermore, we introduce a revised gating scheme for flow cytometry with considerably lower intersubset contamination to facilitate high-purity monocyte subset cell preparations for bulk analyses. We also show that flow cytometry experiment analyzed using multiple redundant markers is an attractive approach to ensure accurate and reproducible identification of monocyte subsets in variable human assays.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Traditional Monocyte Gating Leads to Frequent Misclassification of Monocyte Subsets
We performed CyTOF mass cytometry on human peripheral blood in 6 healthy volunteers using a panel of 36 cell surface markers chosen to interrogate the monocyte system (Table I in the online-only Data Supplement). We reasoned that the 3 principal monocyte subsets would be more accurately defined using the full panel of cell surface markers rather than the traditional approach based solely on CD14 and CD16. Monocyte subsets were defined in the conventional manner by excluding lineage-positive cells (CD66b, CD19, CD3) followed by selection of monocytes using CD14 and HLA-DR expression. Classical, intermediate, and nonclassical monocytes constituted 68.3%, 5.7%, and 20.2% of total blood monocytes, respectively ( Figure 1A ; Figure IA in the online-only Data Supplement). viSNE was performed on total peripheral blood mononuclear cells using all cell surface markers. The 3 monocyte subsets were superimposed on the resulting viSNE map leading to the identification of 3 subpopulations corresponding to each monocyte subset ( Figure 1B ; Figure IB in the online-only Data Supplement). This shows that intermediate and nonclassical populations occupied fixed coordinates on the viSNE map between individuals, whereas the classical monocytes were more heterogeneously distributed between individuals, implying heterogeneity within human classical monocytes as has been observed in mouse. 20 To define the monocyte subsets in an unbiased fashion, we adopted a semisupervised approach. The viSNE results from 6 individuals were combined onto a single plot, and monocyte subset gates were then manually drawn on the viSNE plot to classify each monocyte population using information borrowed over all 36 cell surface markers. It was clear that there was not a distinct separation of the 3 monocyte subsets ( Figure 1C) . We quantified the number of each monocyte subset within these newly defined gates and compared them to the conventional gating strategy ( Figure 1D ). Using the viSNEbased gating, we observed monocyte frequencies that were consistent with previous expectations and significantly higher than we observed with the conventional gating approach, presumably because of the strict lineage gate used in our initial subset identification. Thus, viSNE-based gating of cell populations is an effective strategy for removing lineage-positive cells that avoids under-representing cells of interest that may otherwise be lost. It was apparent from this viSNE-based gating approach that monocytes which were classified as intermediate using the conventional approach were present within all 3 viSNE-defined gates, and a similar trend was seen for leakage of classical and nonclassical monocytes into the intermediate monocyte gate ( Figure 1C ). This led us to speculate that monocytes that are conventionally classified as 1 subset may actually be mixed, an assertion that is not surprising, considering the arbitrary nature of gate placement.
To investigate this proposition, monocytes from each subset defined using viSNE were plotted onto a CD14 versus CD16 biaxial plot ( Figure 1E ). Classical monocytes predominantly resided within the classical monocyte gate, although a significant fraction was found to contain low levels of CD14 and was excluded from conventional monocyte subset gating. Some classical monocytes were also found within the intermediate monocyte gate. viSNE-defined intermediate monocytes were centered on the conventional intermediate monocyte gate, although many of these cells were distributed among all 3 of the conventional gates. Nonclassical monocytes were principally found within the expected gate; however, these cells were also found to contaminate the intermediate monocyte population, and some cells were excluded from conventional monocyte subset gating.
These misclassification events equate to contamination that can bias or lead to the misinterpretation of cell subset function based on bulk measurements, such as RT-PCR, RNA-Seq, or ELISA. We quantified the contamination that occurs with conventional gating using monocyte gates defined by viSNE to determine the true population identity of each monocyte formerly gated using the conventional approach ( Figure 1F ). Classical monocytes were well defined with >99% of conventionally gated classical monocytes falling within the viSNE-defined classical monocyte gate. Strikingly, Figure 1F ). Intermediate monocytes were principally contaminated with nonclassical monocytes, and to a lesser extent, also with classical monocytes. We found that conventionally gated nonclassical monocytes typically contained 5% to 10% intermediate monocytes according to viSNE. These findings show that conventional monocyte gating leads to frequent intersubset contamination. Importantly, these false-positive events cannot be identified or accounted for using the conventional gating approaches.
Prioritization of Cell Surface Markers That Discriminate Human Monocyte Subsets
One approach to overcome the issue of intersubset contamination is to use additional cell surface markers that, in combination, will increase the specificity of monocyte subset identification. To identify the marker pairs that would most optimally work in combination for this purpose, we analyzed cell surface marker profiles of classical, intermediate, and nonclassical monocytes. viSNE analysis performed on an equal number of cells within each monocyte subset showed a good separation of the 3 populations (Figure 2A ). However, viSNE is a highly nonlinear approach that is extremely powerful for classifying populations, yet with this approach, it is not possible to directly determine the specific contribution of individual surface markers to the classification.
To determine these most informative markers, we calculated a discrimination index (DI) for each surface marker between each pair of monocyte populations (Table I in the online-only Data Supplement). The DI is calculated as the difference in the mean signal intensity divided by the sum of the SDs for each marker between a pair of populations and is akin to the staining index commonly used to determine the brightness of fluorochrome-conjugated antibodies in flow cytometry. 21 The 6 markers with the highest DI between each pair of monocyte subsets were chosen, providing a shortlist of a total of 11 informative surface markers (Table) . To validate the potential of these 11 markers to discriminate between the monocyte subsets, we performed principal component analysis (PCA) on viSNE-defined classical, intermediate, and nonclassical monocytes ( Figure 2B ). In combination, these 11 markers explained a considerable amount of variability in the data set, with the primary principal component axis explaining 40.3% of the overall variance and the second principal component accounting for an additional 28.3% of the variance. Importantly, the 3 monocyte subsets, although overlapping, did occupy distinct regions of the PCA. Analysis of the principal component loadings was used to identify the markers responsible for the variability captured in the primary and secondary principal components. The primary principal component axis was dominated by CD16, CD14, CCR2, CD64, CD36, and to a lesser extent CD62L and CD86 ( Figure 2C ), all of which have high DI values for the comparison between classical and nonclassical monocytes (Table) . The secondary principal component axis was explained by HLA-DR, CD163, CD40, CD11c, and CD62L ( Figure 2C ). Markers dominating the second principal component axis were found to discriminate between the intermediate and classical populations based on their DI scores (Table) .
Thus, we have found that cell surface markers discriminating among the 3 monocyte populations have a tendency to separate the intermediate and classical monocytes or the intermediate and nonclassical monocytes, but rarely both (Table) . The main exception to this is HLA-DR which was found to possess high DI values with respect to both the comparisons between both classical and intermediate and nonclassical and intermediate populations. To visualize transitional cell surface marker expression between the monocyte subsets, we used isometric mapping to order clusters of monocyte subsets. 20, 22 Isometric mapping positioned clusters composed of classical, intermediate, and nonclassical monocytes in the anticipated order over the primary isometric mapping axis ( Figure 2D ; Figure IIA and IIB in the online-only Data Supplement). We shortlisted the 6 most informative markers (indicated by an asterisk in the Table) that discriminate the 3 monocyte subsets and plotted the expression of each against the isometric mapping-ordered clusters ( Figure 2D ; Figure IIC in the onlineonly Data Supplement). This clearly shows the retainment of CD14, CCR2, and CD36 on both classical and intermediate monocytes and the loss of these markers on nonclassical monocytes. Conversely, HLA-DR, CD11c, and CD16 were expressed more highly on the intermediate and nonclassical monocytes relative to the classical monocytes, with HLA-DR being highest on the intermediate subset ( Figure 2D ).
Rational Improvement of Monocyte Subset Gating
By quantifying the purity of monocyte subsets gated using the conventional CD14/CD16 method, we have determined that intermediate and nonclassical monocytes are frequently misclassified. It has been proposed that leveraging the shared coexpression of cell surface markers can improve the accuracy of monocyte subset identification. 15 To develop this approach, we must rationally maximize the accuracy of monocyte sorting while minimizing the requirement for additional surface markers needed to ensure compatibility with conventional flow cytometry. Therefore, we incorporated additional markers into hi for intermediate monocytes ( Figure 3A) . To test the efficacy of this sorting scheme, we asked what percentage of the monocyte subsets sorted using our new strategy fall within the viSNE-defined monocyte subset gates. The mean purity of the classical monocyte subset increased from 99.2% to 99.9%, intermediate monocyte purity increased from 86.2% to 98.7%, and nonclassical monocyte purity increased from 87.2% to 99.1% ( Figure 3B and 3C) . We also considered loss of monocytes belonging to each subset as a result of this revised gating approach. Relative to conventional gating, our revised strategy recovered 75.1% of the classical monocytes, 67.9% of the intermediate monocytes, and 78.4% of the nonclassical monocytes ( Figure 3D ). After accounting for removal of the misclassified monocytes, this equates to a loss of 24.1% of the classical, 18.3% of the intermediate, and 8.8% of the classical monocytes, respectively. In summary, the incorporation of additional gating steps can considerably improve the classification and purity of monocyte subsets by excluding false-positive results at the cost of a relatively small loss of true-positive monocytes.
Revised Gating Approach Improves Subset Definition in Conventional Flow Cytometry
We tested the application of our new gating method devised using CyTOF with conventional multicolor flow cytometry. Human peripheral blood was stained with a panel of 8 cell surface markers (7 fluorochrome-conjugated antibodies and a viability dye: CD14, CD16, CD11c, HLA-DR, CD36, CCR2, and a lineage cocktail composed of CD3, CD19, CD66b CD56). Consistent with our CyTOF data, classical monocytes contained the highest expression of CD14, CD36, and CCR2, intermediate monocytes expressed the highest level HLA-DR and high levels of CD14, CD16, CD11c and CD36, whereas nonclassical monocytes highly expressed CD16 and CD11c with somewhat lower levels of HLA-DR ( Figure 4A ). To show that this combination of cell surface markers is sufficient to accurately classify the monocyte subsets, we performed viSNE on total monocytes and overlaid the subsets gated using the traditional approach. The resulting viSNE map clearly shows that the 3 monocyte populations occupy distinct regions of the plot; however, no clear boundary separated the 3 subsets ( Figure 4B ). In contrast, monocytes gated according to our revised strategy showed clearly distinct populations ( Figure 4C ), demonstrating that our revised gating strategy leads to a considerable improvement in the accuracy of monocyte subset classification using conventional flow cytometry. 
Improvement in Monocyte Classification in Clinical CAD Samples
Consistently identifying the 3 monocyte subsets in clinical samples can pose a significant challenge because of the compounding effects of variability that result from genetic diversity, disease severity, sample collection methods, and discrete sample collection time points. Furthermore, the necessity of freezing samples for later analysis can impose a considerable and unavoidable loss of cell surface marker integrity. We reasoned that defining the monocyte subsets using our panel, which incorporates the most informative redundant markers for each population, would improve subset classification in the face of this variability. To explore this possibility, we obtained peripheral blood mononuclear cells from patients stratified on the basis of CAD severity using the Gensini score index as CAD low (<10) and CAD high (>20), respectively.
Monocytes defined using the conventional approach ( Figure 5A ) were used to locate each subpopulation on the viSNE map. Nonclassical, intermediate, and classical monocytes occupied distinct regions that were not affected by disease status ( Figure 5B ; Figure III in the online-only Data Supplement). We did however observe variability in CD16 cell surface staining ( Figure IV in the online-only Data Supplement) that would typically require the arbitrary adjustment of gates on an individual basis to ensure that the correct populations were identified. To overcome this inherent bias, monocyte frequencies were quantified using gates drawn directly onto the viSNE biaxial plot. Increased frequencies of both intermediate and nonclassical monocytes were observed among CAD high individuals ( Figure 5C ) in line with expectations 14 ; however, given the small sample size in this study, these differences were not statistically significant. We observed similar trends in monocyte subset frequencies ( Figure VA in the online-only Data Supplement) and no major differences in monocyte numbers as a percentage when we gated using the traditional method ( Figure VB in the online-only Data Supplement). However, the ranges of subset frequencies are lower using viSNE-based gating, implying a more accurate classification of monocytes by viSNE. Importantly, visualization of cell surface marker expression on the viSNE axes using rainbow plots confirmed that the 3 monocyte populations possess the expected cell surface marker profiles ( Figure 5D ). Furthermore, our optimized gating approach recovered 3 distinct subpopulations in both low CAD and high CAD individuals ( Figure 5E ). Thus, we have shown that our monocyte subset gating scheme facilitates the isolation of highly purified cell preparations during CAD. Furthermore, monocyte subset identification using viSNE coupled with highly informative cell surface markers is a powerful approach for monocyte identification when dealing with heterogeneous clinical samples.
Discussion
Monocytes play diverse roles in infection, inflammation, and wound repair, and changes in the population frequencies of human monocytes are associated with multiple diseases. 2 Consequently, there has been considerable interest in understanding the roles of the various monocyte subsets, particularly during CAD in which the intermediate monocyte population is known to expand, as observed in large-scale epidemiological studies. 15, 23 It is widely appreciated that care must be taken to ensure accurate quantification of monocytes by flow cytometry because of the potential for contamination of CD16-positive monocytes with other CD16-positive cell types, such as neutrophils and natural killer cells. 23 To avoid these issues, monocytes are defined using pan monocytic markers such as CD86 or HLA-DR used in combination with CD14. 24 It is similarly appreciated that care is also required to accurately distinguish among the 3 monocyte subsets, 10 yet this problem still poses a considerable challenge that has not been fully resolved. Indeed, previous studies have reached opposing conclusions concerning the relative relatedness of intermediate monocytes to the classical and nonclassical subsets, which, in fact, may be easily explained by subtle differences in gating between studies. 12, 13 Here, we have presented a novel approach that takes advantage of viSNE and high-dimensional cellular phenotyping using CyTOF to characterize human classical, intermediate, and nonclassical monocytes in unprecedented detail. Our results show that defining the monocyte subsets using CD14 and CD16 alone is insufficient and frequently leads to intersubset contamination, regardless of the applied gating strategy. Furthermore, we observed quite considerable variability between individuals in terms of the degree of contamination. This cross-contamination of monocyte preparations has the potential to compromise the interpretation of monocyte subset function in ex vivo assays for readouts, such as RNA and cytokine expression. Naturally, the consequence of these effects is a reduction in the consistency of results reported between laboratories and increased variability within experiments, leading to a loss of statistical power. Thus, defining monocyte subsets with a single pair of continuously expressed cell surface markers can explain the conflicting reports on subset relationships and functions.
By measuring 36 myeloid-relevant cell surface markers in parallel, we defined the monocyte subsets using the dimension reduction approach viSNE. Subsequently, the cell surface markers that best discriminate between the viSNE-defined monocyte subsets were identified using our DI metric. Classical and intermediate monocytes were best distinguished by CD16, HLA-DR, and CD11c, which were all more highly expressed on intermediate monocytes relative to classical monocytes. We have also obtained excellent results using CD62L as a marker that is more abundant on the classical subset; however, we have found that CD62L is shed on freezing, and so this marker is not compatible with frozen peripheral blood mononuclear cell preparations (data not shown). Intermediate monocytes were best distinguished from nonclassical monocytes using CD14, CCR2, and CD36, all of which were lost on monocyte maturation into the nonclassical subset. Using these highly informative cell surface markers, we have rationally developed a gating strategy that considerably improves the purity of monocyte preparations.
We did not demonstrate significant quantitative differences in monocyte population frequencies when using our revised gating scheme vis-a-vis the traditional gating approach in our atherosclerosis cohort because of the small sample size analyzed. However, our study does indeed demonstrate the use of this new gating scheme in a disease setting in which cell surface marker expression levels could change drastically. Further, our approach of combining viSNE with our optimized panel of redundant markers greatly improves the gating and identification of human monocyte subsets. This provides a true practical advantage for both the quantification and isolation of both nonclassical and intermediate monocyte subsets, in which identification of these 2 subsets is often difficult or simply just not possible without data of the highest quality-a major hurdle when dealing with precious clinical samples, often ones that have been frozen for several years. We have clearly shown that our new panel of cell surface markers is of considerable benefit when identifying monocyte subsets of either low-quality or previously frozen samples.
Our new approach still relies on the sequential gating of continuously distributed cell surface markers and so, at least conceptually, does not distinguish between each subset with absolute certainty. However, using monocyte subset gates defined using viSNE, we empirically demonstrate that our revised method leads to a considerable improvement in the purity of monocyte preparations. More generally, our approach involves cross-validating the accuracy of cell populations defined using hierarchical gating with a small number of markers using viSNE as an unbiased high-dimensional classifier. Our approach is akin to backgating analysis with the advantage that cells that are not in the target viSNE gate are easily classified based on the 2-dimensional viSNE axes. This allows the rapid phenotyping and quantification of contaminating cell types in gating scheme, enabling the rational exclusion of such contaminants. Because viSNE and similar tools are commonly available in flow cytometry analysis packages such as Cytobank, this approach is broadly accessible to the research community.
There are clear benefits to the use of this gating strategy for molecular studies of monocyte subset function; however, the use of this approach in population studies may warrant consideration on a case-by-case basis. However, we do note that the dedication of 6 fluorophore channels for monocyte identification does impose drawbacks, such as increased antibody costs and restrictions on the number of other cell types that may be assayed concurrently. The choice to commit 6 cell surface markers for monocyte phenotyping may present a significant cost relative to the use of 2 cell surface markers in the traditional gating scheme.
In summary, we have shown that viSNE is a powerful tool for the classification of cell populations in heterogeneous and difficult to handle samples such as frozen peripheral blood mononuclear cells. Specifically, using our flow cytometry staining panel that is designed to incorporate multiple, redundant, cell surface markers, the monocyte subsets can be robustly identified. Given these benefits, we hope that the adoption of our revised gating scheme will improve consistency in reports of monocyte functions between studies enabling a more robust consensus on monocyte subset functions.
